Division of Therapeutics Research and Infectious Disease Epidemiology (TIDE)
About the Division
We conduct research in pharmacoepidemiology and in surveillance, reporting, and control of both hospital and community acquired infections. TIDE also features a growing portfolio of work in informatics.
Leadership
Our leadership team, the TIDE Strategy Board, includes Richard Platt, Darren Toh, Michael Klompas, and Kim Lane.
Research
Research Areas
This program investigates the effectiveness, safety, and appropriate use of marketed drugs and vaccines. Activities focus on generation of new knowledge through investigator-initiated grants that analyze real-world data, and development of better analytic methods to perform pharmacoepidemiologic research. We lead several distributed data networks to support therapeutics research and surveillance programs.
We lead public-private partnerships between academic centers, health care organizations, and the traditional public health community focusing on the identification and reporting of notifiable infectious diseases and on HIV prevention and sexual health promotion. Our ongoing initiatives aim to enhance surveillance, reporting, prevention, and management of serious infections in hospitals and communicable diseases within the broader population and to improve the implementation of preexposure prophylaxis across a variety of health care delivery settings.
Our vision is to build an internationally recognized program that utilizes cutting-edge innovations in health information technology to improve how epidemiologists, researchers, clinicians, and other healthcare workers share, use and understand health-related data. We facilitate population health research by leveraging existing data resources and harnessing emerging technologies.
Research Projects
Impact
Who We Are

Join our team!
We embody a diverse collection of talents, expertise, and backgrounds, cultivating a dynamic and collaborative environment.
TIDE Seminars
Our TIDE Research Seminar Series features quarterly talks by experts across the fields of Pharmacoepidemiology and Infectious Disease. Reach out to learn the latest.